These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 3074153)

  • 21. Complement activating property of the protein-rich endotoxin (OEP) of Pseudomonas aeruginosa. I. Activation of both the classical and the alternative pathways of guinea pig complement.
    Inada K
    Jpn J Exp Med; 1980 Feb; 50(1):13-21. PubMed ID: 6770130
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of complement activation by a secreted Staphylococcus aureus protein.
    Lee LY; Höök M; Haviland D; Wetsel RA; Yonter EO; Syribeys P; Vernachio J; Brown EL
    J Infect Dis; 2004 Aug; 190(3):571-9. PubMed ID: 15243934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The classical complement pathway plays a critical role in the opsonisation of uropathogenic Escherichia coli.
    Li K; Sacks SH; Sheerin NS
    Mol Immunol; 2008 Feb; 45(4):954-62. PubMed ID: 17870166
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complement activation by carotenoid derived aldehydes in cultured human vein epithelial cells.
    Wu PL; Lin GH; Kang XD; Yuan H; Shen YL
    Phytother Res; 2009 Dec; 23(12):1696-700. PubMed ID: 19441061
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The septic burned patient: a model for studying the role of complement and immunoglobulins in opsonization of opportunist micro-organisms.
    Bjornson AB; Altemeier WA; Bjornson HS
    Ann Surg; 1979 Apr; 189(4):515-27. PubMed ID: 109057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple effects of a diamidine (propamidine) on complement activation.
    Vogt W; Hinsch B; Schmidt G; Von Zabern I
    Immunology; 1979 Jan; 36(1):131-7. PubMed ID: 422224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of complement C3 opsonization, C5a receptor, and CD14 in E. coli-induced up-regulation of granulocyte and monocyte CD11b/CD18 (CR3), phagocytosis, and oxidative burst in human whole blood.
    Brekke OL; Christiansen D; Fure H; Fung M; Mollnes TE
    J Leukoc Biol; 2007 Jun; 81(6):1404-13. PubMed ID: 17389579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cefotaxime: rate of bacterial killing and interactions with serum and leukocyte activity.
    Gialdroni Grassi G; Mangiarotti P; Fietta A
    Acta Med Port; 1983 Mar; 4(3):167-71. PubMed ID: 6305143
    [No Abstract]   [Full Text] [Related]  

  • 29. Mechanism of action of an inhibitor of complement-mediated prevention of immune precipitation.
    Ahmed AE; Veitch J; Whaley K
    Immunology; 1990 Jun; 70(2):139-44. PubMed ID: 2373514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complement-mediated phagocytosis of Pseudomonas aeruginosa.
    Peterson PK; Kim Y; Schmeling D; Lindemann M; Verhoef J; Quie PG
    J Lab Clin Med; 1978 Dec; 92(6):883-94. PubMed ID: 105067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of the complement system and leukocyte recruitment by Tityus serrulatus scorpion venom.
    Bertazzi DT; de Assis-Pandochi AI; Talhaferro VL; Caleiro Seixas Azzolini AE; Pereira Crott LS; Arantes EC
    Int Immunopharmacol; 2005 Jun; 5(6):1077-84. PubMed ID: 15829423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Eosinophil granule major basic protein regulates generation of classical and alternative-amplification pathway C3 convertases in vitro.
    Weiler JM; Gleich GJ
    J Immunol; 1988 Mar; 140(5):1605-10. PubMed ID: 3346544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic inhibition of the early phase of complement activation.
    Roos A; Ramwadhdoebé TH; Nauta AJ; Hack CE; Daha MR
    Immunobiology; 2002 Sep; 205(4-5):595-609. PubMed ID: 12396018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Auto-antibody dependent activation of the autologous classical complement pathway by guinea-pig red cells treated with influenza virus or neuraminidase: in vitro and in vivo study.
    Lambre CR; Thibon M; Le Maho S; Di Bella G
    Immunology; 1983 Jun; 49(2):311-9. PubMed ID: 6852870
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Interaction of cefotaxime and normal human serum in the bacteriocidal process against strains of Escherichia coli producing surface K1 antigen].
    Franiczek R; Jankowski S
    Med Dosw Mikrobiol; 1993; 45(1):61-4. PubMed ID: 8231445
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of the classical pathway of complement by tobacco glycoprotein (TGP).
    Koethe SM; Nelson KE; Becker CG
    J Immunol; 1995 Jul; 155(2):826-35. PubMed ID: 7608560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complement activation in vitro induced by endotoxin and injured tissue.
    Heideman M
    J Surg Res; 1979 Jun; 26(6):670-3. PubMed ID: 376946
    [No Abstract]   [Full Text] [Related]  

  • 38. Inhibition of complement activation by intravenous immunoglobulins.
    Qi M; Schifferli JA
    Arthritis Rheum; 1995 Jan; 38(1):146. PubMed ID: 7818565
    [No Abstract]   [Full Text] [Related]  

  • 39. Complement pathway activity in the opsonization of cefotaxime-treated Escherichia coli by normal human serum.
    Shaio MF; Chang FY; Chou MY
    Taiwan Yi Xue Hui Za Zhi; 1988 Jul; 87(7):712-20. PubMed ID: 3074153
    [No Abstract]   [Full Text] [Related]  

  • 40. Complement pathway activity in the opsonization of mutant strains of Salmonella typhimurium.
    Shaio MF; Rowland H
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1986 May; 19(2):137-52. PubMed ID: 3102176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.